AbbVie (ABBV) Price/OCF Ratio: History & Chart

AbbVie Inc.(ABBV)

Drug Manufacturers - General · North Chicago, IL

$260.30-1.42 (-0.54%)

Delayed quote: Sep 3, 2026, 3:59 PM EDT

About AbbVie Inc.

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.

North Chicago, IL

57,000 employees

www.abbvie.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Robert A. Michael

View full financials

ABBV Price/OCF Ratio Metrics

PRICE/OCF RATIO

23.63

PRICE/OCF RATIO AVG TTM

20.03

PRICE/OCF RATIO AVG 3Y

17.22

PRICE/OCF RATIO AVG 5Y

14.74

PRICE/OCF RATIO AVG 10Y

13.50

PRICE/OCF RATIO AVG 15Y

14.13

PRICE/OCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+17.97%

CURRENT VS 3Y AVG

+37.26%

CURRENT VS 5Y AVG

+60.34%

CURRENT VS 10Y AVG

+75.09%

CURRENT VS 15Y AVG

+67.18%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

16.42

median of 83 covered companies

CURRENT VS SECTOR MEDIAN

+43.91%

vs the sector median at left

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
AbbVie Inc. (ABBV)	$459.90B	23.63	20.03	17.22	14.74
Merck & Co., Inc. (MRK)vs ›	$376.25B	18.86	15.71	15.97	15.64
UnitedHealth Group Incorporated (UNH)vs ›	$364.11B	13.40	13.96	20.84	19.63
Roche Holding AG (RHHBY)vs ›	$352.00B	N/A	N/A	N/A	N/A
AstraZeneca PLC (AZN)vs ›	$255.54B	18.61	19.46	19.77	21.90
Johnson & Johnson (JNJ)vs ›	$670.99B	28.66	23.12	18.92	19.19
Amgen Inc. (AMGN)vs ›	$239.70B	19.36	16.32	17.26	15.99
Thermo Fisher Scientific Inc. (TMO)vs ›	$229.82B	25.05	25.27	24.14	24.23
Novo Nordisk A/S (NVO)vs ›	$210.97B	10.25	11.43	22.81	24.69
Abbott Laboratories (ABT)vs ›	$188.27B	19.15	20.89	24.13	22.45

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

AbbVie Inc. (ABBV)

$459.90B

23.63

20.03

17.22

14.74

Merck & Co., Inc. (MRK)vs ›

$376.25B

18.86

15.71

15.97

15.64

UnitedHealth Group Incorporated (UNH)vs ›

$364.11B

13.40

13.96

20.84

19.63

Roche Holding AG (RHHBY)vs ›

$352.00B

N/A

AstraZeneca PLC (AZN)vs ›

$255.54B

18.61

19.46

19.77

21.90

Johnson & Johnson (JNJ)vs ›

$670.99B

28.66

23.12

18.92

19.19

Amgen Inc. (AMGN)vs ›

$239.70B

19.36

16.32

17.26

15.99

Thermo Fisher Scientific Inc. (TMO)vs ›

$229.82B

25.05

25.27

24.14

24.23

Novo Nordisk A/S (NVO)vs ›

$210.97B

10.25

11.43

22.81

24.69

Abbott Laboratories (ABT)vs ›

$188.27B

19.15

20.89

24.13

22.45

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio FAQ

What is the Price/OCF ratio for AbbVie Inc. (ABBV)?

The Price/OCF ratio for ABBV stock is 23.63.

Is AbbVie Inc.'s Price/OCF ratio high or low?

The Price/OCF ratio of 23.63 is 60% above its 5-year average of 14.74, near the high end of its 5-year range (9.08–24.15).

What is the TTM average Price/OCF ratio for AbbVie Inc. (ABBV)?

The TTM average Price/OCF ratio for ABBV stock is 20.03.

What is the 3Y average Price/OCF ratio for AbbVie Inc. (ABBV)?

The 3Y average Price/OCF ratio for ABBV stock is 17.22.

What is the 5Y average Price/OCF ratio for AbbVie Inc. (ABBV)?

The 5Y average Price/OCF ratio for ABBV stock is 14.74.

What is the 10Y average Price/OCF ratio for AbbVie Inc. (ABBV)?

The 10Y average Price/OCF ratio for ABBV stock is 13.50.

What is the 15Y average Price/OCF ratio for AbbVie Inc. (ABBV)?

The 15Y average Price/OCF ratio for ABBV stock is 14.13.

DATE	PRICE/OCF RATIO
2026-09-03	23.63
2026-09-02	23.76
2026-09-01	23.60
2026-08-31	23.28
2026-08-28	23.19
2026-08-27	23.44
2026-08-26	23.87
2026-08-25	24.13
2026-08-24	24.02
2026-08-21	24.06
2026-08-20	23.77
2026-08-19	24.15
2026-08-18	23.51
2026-08-17	22.73
2026-08-14	22.65
2026-08-13	22.77
2026-08-12	22.58
2026-08-11	22.71
2026-08-10	22.51
2026-08-07	22.34
2026-08-06	22.14
2026-08-05	22.35
2026-08-04	22.13
2026-08-03	22.25
2026-07-31	20.97
2026-07-30	21.52
2026-07-29	22.01
2026-07-28	22.00
2026-07-27	21.47
2026-07-24	21.68
2026-07-23	21.47
2026-07-22	21.17
2026-07-21	21.41
2026-07-20	21.18
2026-07-17	21.27
2026-07-16	21.26
2026-07-15	20.40
2026-07-14	20.46
2026-07-13	20.73
2026-07-10	20.74
2026-07-09	20.89
2026-07-08	21.13
2026-07-07	21.28
2026-07-06	21.29
2026-07-02	21.82
2026-07-01	20.98
2026-06-30	21.03
2026-06-29	21.26
2026-06-26	21.18
2026-06-25	20.32
2026-06-24	19.63
2026-06-23	19.62
2026-06-22	19.23
2026-06-18	18.10
2026-06-17	18.49
2026-06-16	18.60
2026-06-15	18.52
2026-06-12	19.03
2026-06-11	18.79
2026-06-10	18.80
2026-06-09	18.84
2026-06-08	18.65
2026-06-05	18.99
2026-06-04	18.80
2026-06-03	18.15
2026-06-02	18.00
2026-06-01	17.80
2026-05-29	18.20
2026-05-28	18.27
2026-05-27	18.00
2026-05-26	17.81
2026-05-22	18.03
2026-05-21	17.93
2026-05-20	17.75
2026-05-19	17.87
2026-05-18	17.50
2026-05-15	17.59
2026-05-14	17.62
2026-05-13	17.43
2026-05-12	17.37
2026-05-11	16.95
2026-05-08	16.85
2026-05-07	18.90
2026-05-06	19.11
2026-05-05	19.21
2026-05-04	19.40
2026-05-01	19.26
2026-04-30	19.70
2026-04-29	19.01
2026-04-28	18.43
2026-04-27	18.40
2026-04-24	18.52
2026-04-23	18.73
2026-04-22	18.69
2026-04-21	19.12
2026-04-20	18.99
2026-04-17	19.43
2026-04-16	19.48
2026-04-15	19.43
2026-04-14	19.60
2026-04-13	19.25
2026-04-10	19.38
2026-04-09	19.80
2026-04-08	19.72
2026-04-07	19.24
2026-04-06	19.27
2026-04-02	19.47
2026-04-01	20.04
2026-03-31	20.27
2026-03-30	19.87
2026-03-27	19.52
2026-03-26	19.68
2026-03-25	19.31
2026-03-24	19.13
2026-03-23	19.10
2026-03-20	19.12
2026-03-19	19.23
2026-03-18	19.42
2026-03-17	20.49
2026-03-16	20.64
2026-03-13	20.48
2026-03-12	21.01
2026-03-11	21.22
2026-03-10	21.16
2026-03-09	21.20
2026-03-06	21.45
2026-03-05	21.66
2026-03-04	22.02
2026-03-03	21.80
2026-03-02	21.84
2026-02-27	21.63
2026-02-26	20.95
2026-02-25	21.15
2026-02-24	21.30
2026-02-23	21.39
2026-02-20	20.96
2026-02-19	19.06
2026-02-18	19.43
2026-02-17	19.78
2026-02-13	19.67
2026-02-12	19.33
2026-02-11	18.76
2026-02-10	18.89
2026-02-09	18.97
2026-02-06	18.98
2026-02-05	18.61
2026-02-04	18.44
2026-02-03	19.17
2026-02-02	19.17
2026-01-30	18.94
2026-01-29	18.72
2026-01-28	18.58
2026-01-27	19.02
2026-01-26	18.75
2026-01-23	18.63
2026-01-22	18.53
2026-01-21	18.36
2026-01-20	18.18
2026-01-16	18.21
2026-01-15	18.41
2026-01-14	18.85
2026-01-13	18.75
2026-01-12	18.69
2026-01-09	18.70
2026-01-08	19.04
2026-01-07	19.83
2026-01-06	19.02
2026-01-05	18.70
2026-01-02	19.48
2025-12-31	19.41
2025-12-30	19.52
2025-12-29	19.61
2025-12-26	19.54
2025-12-24	19.53
2025-12-23	19.44
2025-12-22	19.36
2025-12-19	19.27
2025-12-18	18.93
2025-12-17	19.05
2025-12-16	19.00
2025-12-15	19.32
2025-12-12	18.97
2025-12-11	19.03
2025-12-10	19.13
2025-12-09	18.94
2025-12-08	18.95
2025-12-05	19.20
2025-12-04	19.43
2025-12-03	19.56
2025-12-02	19.06
2025-12-01	19.12
2025-11-28	19.34
2025-11-26	19.34
2025-11-25	19.69
2025-11-24	19.50
2025-11-21	20.07
2025-11-20	19.49
2025-11-19	19.79
2025-11-18	19.87
2025-11-17	19.88
2025-11-14	19.74
2025-11-13	19.73
2025-11-12	19.81
2025-11-11	19.13
2025-11-10	18.58
2025-11-07	18.62
2025-11-06	18.61
2025-11-05	18.41
2025-11-04	18.34
2025-11-03	19.48
2025-10-31	20.04
2025-10-30	20.97
2025-10-29	20.69
2025-10-28	20.91
2025-10-27	20.95
2025-10-24	20.95
2025-10-23	20.97
2025-10-22	21.01
2025-10-21	21.26
2025-10-20	21.33
2025-10-17	21.10
2025-10-16	20.85
2025-10-15	20.79
2025-10-14	21.06
2025-10-13	21.16
2025-10-10	21.18
2025-10-09	21.20
2025-10-08	21.25
2025-10-07	21.40
2025-10-06	21.15
2025-10-03	21.50
2025-10-02	21.74
2025-10-01	22.46
2025-09-30	21.28
2025-09-29	20.51
2025-09-26	20.27
2025-09-25	20.08
2025-09-24	20.22
2025-09-23	20.46
2025-09-22	20.45
2025-09-19	20.44
2025-09-18	20.40
2025-09-17	20.29
2025-09-16	19.87
2025-09-15	20.00
2025-09-12	20.06
2025-09-11	20.24
2025-09-10	19.45
2025-09-09	19.34
2025-09-08	19.28
2025-09-05	19.53
2025-09-04	19.57
2025-09-03	19.47
2025-09-02	19.47
2025-08-29	19.33
2025-08-28	19.11
2025-08-27	19.12
2025-08-26	19.15
2025-08-25	19.07
2025-08-22	19.35

DATE

PRICE/OCF RATIO

2026-09-03

23.63

2026-09-02

23.76

2026-09-01

23.60

2026-08-31

23.28

2026-08-28

23.19

2026-08-27

23.44

2026-08-26

23.87

2026-08-25

24.13

2026-08-24

24.02

2026-08-21

24.06

2026-08-20

23.77

2026-08-19

24.15

2026-08-18

23.51

2026-08-17

22.73

2026-08-14

22.65

2026-08-13

22.77

2026-08-12

22.58

2026-08-11

22.71

2026-08-10

22.51

2026-08-07

22.34

2026-08-06

22.14

2026-08-05

22.35

2026-08-04

22.13

2026-08-03

22.25

2026-07-31

20.97

2026-07-30

21.52

2026-07-29

22.01

2026-07-28

22.00

2026-07-27

21.47

2026-07-24

21.68

2026-07-23

21.47

2026-07-22

21.17

2026-07-21

21.41

2026-07-20

21.18

2026-07-17

21.27

2026-07-16

21.26

2026-07-15

20.40

2026-07-14

20.46

2026-07-13

20.73

2026-07-10

20.74

2026-07-09

20.89

2026-07-08

21.13

2026-07-07

21.28

2026-07-06

21.29

2026-07-02

21.82

2026-07-01

20.98

2026-06-30

21.03

2026-06-29

21.26

2026-06-26

21.18

2026-06-25

20.32

2026-06-24

19.63

2026-06-23

19.62

2026-06-22

19.23

2026-06-18

18.10

2026-06-17

18.49

2026-06-16

18.60

2026-06-15

18.52

2026-06-12

19.03

2026-06-11

18.79

2026-06-10

18.80

2026-06-09

18.84

2026-06-08

18.65

2026-06-05

18.99

2026-06-04

18.80

2026-06-03

18.15

2026-06-02

18.00

2026-06-01

17.80

2026-05-29

18.20

2026-05-28

18.27

2026-05-27

18.00

2026-05-26

17.81

2026-05-22

18.03

2026-05-21

17.93

2026-05-20

17.75

2026-05-19

17.87

2026-05-18

17.50

2026-05-15

17.59

2026-05-14

17.62

2026-05-13

17.43

2026-05-12

17.37

2026-05-11

16.95

2026-05-08

16.85

2026-05-07

18.90

2026-05-06

19.11

2026-05-05

19.21

2026-05-04

19.40

2026-05-01

19.26

2026-04-30

19.70

2026-04-29

19.01

2026-04-28

18.43

2026-04-27

18.40

2026-04-24

18.52

2026-04-23

18.73

2026-04-22

18.69

2026-04-21

19.12

2026-04-20

18.99

2026-04-17

19.43

2026-04-16

19.48

2026-04-15

19.43

2026-04-14

19.60

2026-04-13

19.25

2026-04-10

19.38

2026-04-09

19.80

2026-04-08

19.72

2026-04-07

19.24

2026-04-06

19.27

2026-04-02

19.47

2026-04-01

20.04

2026-03-31

20.27

2026-03-30

19.87

2026-03-27

19.52

2026-03-26

19.68

2026-03-25

19.31

2026-03-24

19.13

2026-03-23

19.10

2026-03-20

19.12

2026-03-19

19.23

2026-03-18

19.42

2026-03-17

20.49

2026-03-16

20.64

2026-03-13

20.48

2026-03-12

21.01

2026-03-11

21.22

2026-03-10

21.16

2026-03-09

21.20

2026-03-06

21.45

2026-03-05

21.66

2026-03-04

22.02

2026-03-03

21.80

2026-03-02

21.84

2026-02-27

21.63

2026-02-26

20.95

2026-02-25

21.15

2026-02-24

21.30

2026-02-23

21.39

2026-02-20

20.96

2026-02-19

19.06

2026-02-18

19.43

2026-02-17

19.78

2026-02-13

19.67

2026-02-12

19.33

2026-02-11

18.76

2026-02-10

18.89

2026-02-09

18.97

2026-02-06

18.98

2026-02-05

18.61

2026-02-04

18.44

2026-02-03

19.17

2026-02-02

19.17

2026-01-30

18.94

2026-01-29

18.72

2026-01-28

18.58

2026-01-27

19.02

2026-01-26

18.75

2026-01-23

18.63

2026-01-22

18.53

2026-01-21

18.36

2026-01-20

18.18

2026-01-16

18.21

2026-01-15

18.41

2026-01-14

18.85

2026-01-13

18.75

2026-01-12

18.69

2026-01-09

18.70

2026-01-08

19.04

2026-01-07

19.83

2026-01-06

19.02

2026-01-05

18.70

2026-01-02

19.48

2025-12-31

19.41

2025-12-30

19.52

2025-12-29

19.61

2025-12-26

19.54

2025-12-24

19.53

2025-12-23

19.44

2025-12-22

19.36

2025-12-19

19.27

2025-12-18

18.93

2025-12-17

19.05

2025-12-16

19.00

2025-12-15

19.32

2025-12-12

18.97

2025-12-11

19.03

2025-12-10

19.13

2025-12-09

18.94

2025-12-08

18.95

2025-12-05

19.20

2025-12-04

19.43

2025-12-03

19.56

2025-12-02

19.06

2025-12-01

19.12

2025-11-28

19.34

2025-11-26

19.34

2025-11-25

19.69

2025-11-24

19.50

2025-11-21

20.07

2025-11-20

19.49

2025-11-19

19.79

2025-11-18

19.87

2025-11-17

19.88

2025-11-14

19.74

2025-11-13

19.73

2025-11-12

19.81

2025-11-11

19.13

2025-11-10

18.58

2025-11-07

18.62

2025-11-06

18.61

2025-11-05

18.41

2025-11-04

18.34

2025-11-03

19.48

2025-10-31

20.04

2025-10-30

20.97

2025-10-29

20.69

2025-10-28

20.91

2025-10-27

20.95

2025-10-24

20.95

2025-10-23

20.97

2025-10-22

21.01

2025-10-21

21.26

2025-10-20

21.33

2025-10-17

21.10

2025-10-16

20.85

2025-10-15

20.79

2025-10-14

21.06

2025-10-13

21.16

2025-10-10

21.18

2025-10-09

21.20

2025-10-08

21.25

2025-10-07

21.40

2025-10-06

21.15

2025-10-03

21.50

2025-10-02

21.74

2025-10-01

22.46

2025-09-30

21.28

2025-09-29

20.51

2025-09-26

20.27

2025-09-25

20.08

2025-09-24

20.22

2025-09-23

20.46

2025-09-22

20.45

2025-09-19

20.44

2025-09-18

20.40

2025-09-17

20.29

2025-09-16

19.87

2025-09-15

20.00

2025-09-12

20.06

2025-09-11

20.24

2025-09-10

19.45

2025-09-09

19.34

2025-09-08

19.28

2025-09-05

19.53

2025-09-04

19.57

2025-09-03

19.47

2025-09-02

19.47

2025-08-29

19.33

2025-08-28

19.11

2025-08-27

19.12

2025-08-26

19.15

2025-08-25

19.07

2025-08-22

19.35

Price/OCF Ratio: 23.63

ABBV Price/OCF Ratio Chart

ABBV Average Price/OCF Ratio Chart

ABBV Current vs Average Price/OCF Ratio Chart

ABBV Price/OCF Ratio Metrics

ABBV Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Price/OCF Ratio FAQ

ABBV Price/OCF Ratio History

Related Metrics